Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Relapse rates
RCT	509 people with Graves' hyperthyroidism	Proportion of people relapsing 12 months 36% with thiamazole 10 mg daily 37% with thiamazole 40 mg daily Absolute numbers not reported	P value not reported Reported as not significant		Not significant